[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:gastroesophageal-junction-adenocarcinoma:msi1-gene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Gastroesophageal Junction Adenocarcinoma","MSI1 Gene",8,[8,16,22,29,36,42,48,54],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06203600","Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial",[12],"Phase 2\u002FPhase 3","RECRUITING","2026-08-26T02:17:28.381459Z","2026-05-05T02:43:28.966545Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07001748","Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity",[12],"2026-08-26T02:15:43.339060Z","2026-05-05T02:43:27.952061Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT03526835","A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors",[26],"Phase 1\u002FPhase 2","2026-08-26T02:17:16.126291Z","2026-07-30T01:46:14.461456Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT06789172","A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors",[33],"Phase 1","2026-08-26T02:16:18.872924Z","2026-07-05T05:32:16.698119Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT07262619","EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors",[26],"2026-08-26T02:15:09.079045Z","2026-05-05T02:43:28.515153Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT05107674","A Study of NX-1607 in Adults With Advanced Malignancies",[33],"2026-08-26T02:16:02.918558Z","2026-05-05T02:43:28.117316Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT05086692","A Beta-only IL-2 ImmunoTherapY Study",[26],"2026-08-26T02:18:31.164304Z","2026-05-05T02:35:31.708594Z",{"nct_id":55,"title":56,"phases":57,"status":58,"updated_at":59,"content_modified":60},"NCT07594548","Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma",[33],"NOT_YET_RECRUITING","2026-08-26T02:17:36.611194Z","2026-05-29T15:36:40.205969Z"]